Vectura Group plc is a British pharmaceutical company that specializes in the development of inhaled therapies for respiratory diseases. Founded in 1997, the company has grown to become a leading player in the global pharmaceutical industry, with a portfolio of innovative products that are used by millions of patients worldwide. Vectura’s products are designed to provide targeted treatments for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, among others. The company is headquartered in Chippenham, Wiltshire, and has operations in the UK, the US, and Europe. Vectura is committed to advancing the science of respiratory medicine and improving the lives of patients with respiratory conditions.
